Cleerly LABS vs HealthCCSng
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely characterize atherosclerosis, quantify plaque volume and type, and assess stenosis severity. This tool is ideal for detailed personalized heart disease management, including tracking disease progression and evaluating potential ischemia, offering a deeper insight beyond just calcium scoring.
View Cleerly LABS →Choose HealthCCSng if…
Choose HealthCCSng if your primary goal is the automated detection and quantification of coronary artery calcification (CAC) from routine, non-contrast chest CT scans. This solution is best suited for opportunistic screening to identify patients at risk of coronary artery disease by providing a quick, numerical calcium score and categorization without requiring dedicated cardiac imaging.
View HealthCCSng →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | HealthCCSng |
|---|---|---|
| Pricing | Per analysis | Not publicly available |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-based, integrates with PACS and EMR systems |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools are cloud-based and integrate with existing PACS/RIS/EMR systems, suggesting a focus on seamless workflow integration. Tool B emphasizes an 'automated workflow for results without human intervention,' which could imply a simpler user experience for basic CAC scoring. However, Tool A offers comprehensive 3D visualization and tracking of disease progression, which, while potentially more complex, provides richer interactive capabilities.
Clinical Value
Cleerly LABSTool A (Cleerly LABS) offers a significantly more comprehensive analysis by detecting, quantifying, and characterizing atherosclerosis and stenosis, including plaque volume and type, and even ischemia with an additional module. Tool B (HealthCCSng) focuses solely on detecting and quantifying coronary artery calcification (CAC). While CAC is a valuable risk indicator, Tool A provides a deeper, more personalized assessment of heart disease.
Pricing & Value
Cleerly LABSTool A (Cleerly LABS) provides transparent pricing information, including a retail price and a discounted offer, along with details on insurance coverage. Tool B (HealthCCSng) states its pricing is 'not publicly available,' requiring direct vendor contact. While Tool A's cost is high, its transparency and the comprehensive nature of its analysis offer a clearer value proposition compared to Tool B's opaque pricing.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, cloud-based, and designed for integration with PACS and EMR systems. Tool A explicitly mentions AWS deployment and an on-site proxy for data transfer, while Tool B's BAA is listed as 'likely' rather than explicitly confirmed. However, both appear well-equipped for deployment within healthcare enterprises.
Innovation
Cleerly LABSTool A (Cleerly LABS) demonstrates higher innovation by providing comprehensive coronary plaque assessment, including volume and type, and stenosis detection from CCTA, moving beyond simple calcification to a more nuanced understanding of atherosclerosis. While Tool B's ability to analyze routine, non-gated CT scans for CAC is innovative for opportunistic screening, Tool A's depth of diagnostic capability represents a more advanced step in cardiovascular imaging analysis.
Support & Docs
Cleerly LABSCleerly (Tool A) provides clear information regarding its customer support availability, including operating hours and dedicated channels for client support. For HealthCCSng (Tool B), while integration and ease of use are mentioned, specific details about customer support structures or publicly accessible documentation are not readily available in the provided information or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | HealthCCSng |
|---|---|---|
| Name | Cleerly LABS | HealthCCSng |
| Company | Cleerly | Nano-X AI |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. |
| Primary Analysis Focus | Comprehensive coronary plaque assessment (volume, type), stenosis, ischemia detection (with Cleerly ISCHEMIA module) | Coronary Artery Calcification (CAC) detection and quantification |
| Input Scan Type | Coronary CT angiography (CCTA) | Non-contrast, non-ECG gated chest CT scans |
| Integration | PACS, RIS, EHR via Cleerly Proxy | PACS and EMR systems |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and HealthCCSng.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or HealthCCSng
Backers
Who funded each tool's parent company.